Prevalence of dyslipidemia in outpatients of the Spanish health service: The HISPALIPID Study;Prevalencia de dislipemia en las consultas ambulatorias del Sistema Nacional de Salud: Estudio HISPALIPID

Medicina Clinica

Volumn 127, Issue 9, 2006, Pages 331-334

  Vegazo, Onofre ^a,b   Banegas, Jose R ^c,d   Civeira, Fernando ^e   Serrano Aisa, Pedro L ^e   Javier Jimenez F ^a,b   Luengo, Emilio ^f  

^a ASTRAZENECA   (United Kingdom)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Centro de Salud Nazaret   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^f Hospital General de la Defensa   (Spain)

Author keywords

Cardiovascular Risk Factors; Dyslipidemia; Prevalence; Spain

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTPATIENT DEPARTMENT; PHYSICIAN; PREVALENCE; PRIMARY MEDICAL CARE;

EID: 33750086344     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13092314     Document Type: Article

References (10)

1. Villar Álvarez F, Maiques Galán A, Brotons Cuixart C, Torcal Laguna J, Banegas Banegas JR, Lorenzo Piqueres A, et al. Recomendaciones preventivas cardiovasculares en atención primaria. Aten Primaria. 2005;36:11-26.
2. Law M, Wald NJ. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90.056 participants in 14 randomised trials of statins. Cholesterol Treatment Trialists' Collaboration. Lancet. 2005;366: 1267-78.
3. Villar Álvarez F, Banegas Banegas JR, Donado Campos JM, Rodríguez Artalejo F. Las enfermedades cardiovasculares y sus factores de riesgo en España: hechos y cifras. Informe SEA 2003. Madrid: Ergon; 2003. p. 43-52.
4. Tolonen H, Keil U, Ferrario M, Evans A, for the WHO MONICA Project. Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project. Int J Epidemiol. 2005;34:181-92.
5. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. Lancet. 2001;357:995-1001.
6. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA. 2001;285: 2486-97.
7. The Seven Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA. 2003; 289:2560-72.
8. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care. 2002;25:S5-S20.
9. Instituto Nacional de Estadística. Módulo de Salud 1999. [Accedido 19-2-2006.] Disponible en URL: http://www.ine.es/inebase/
10. Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M. Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales. Med Clin (Barc). 2005;124:606-12.